WE vs ONCO
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
WE
Read full descriptionHide full description
The WE-ACT app is designed to promote better communication between cancer patients and their employers and between cancer patients and their healthcare teams. This app contains helpful information for cancer patients to use during and after treatment. Victoria Blinder, MD, MSc, is a board certified medical oncologist at Memorial Sloan Kettering Cancer Center with a practice that is dedicated to the treatment of patients with cancer. Her research focuses on understanding and addressing disparities in cancer outcomes. She is the primary investigator of the WE-ACT Study, which tests an early version of this mobile health app designed to help cancer patients keep their jobs during and after treatment. Medical Disclosure: This mobile application (βAppβ) is operated by Memorial Sloan Kettering Cancer Center (βMSKβ) and is intended only for users who consented to take part in the research study named Talking to Employers and Medical Staff About Work (WE-ACT). THIS APP IS NOT TO BE USED AS A SUBSTITUTE FOR MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT OF ANY HEALTH CONDITION OR PROBLEM. ANY QUESTIONS REGARDING YOUR OWN HEALTH SHOULD BE ADDRESSED TO YOUR OWN PHYSICIAN OR OTHER HEALTHCARE PROVIDER. The App may contain links to external websites or mobile applications that are not owned or operated by MSK (the βExternal Contentβ). MSK does not control External Content and we are not responsible for the content or performance of those sites. A link to External Content does not imply any agreement with or endorsement of the External Content or any association with the owner or operators of the External Content. You are responsible for viewing and abiding by the terms and conditions of use and the privacy statements of the External Content.
ONCO
Read full descriptionHide full description
ONCO-NET: Oncology Navigation Empowerment for Treatment. Get connected with local resources who may provide assistance to help relieve the financial burden associated with the cost of cancer treatment.
Screenshots
Verdict
The clearest difference is update cadence: ONCO at every 9 days against WE's every 6 months. ONCO also leads on iOS requirement (13.0 vs 15.6). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
WE ships an update every 6 months, ONCO every 9 days. The most recent releases landed on November 7, 2026 and November 2, 2026 respectively.
| Parameter | WE | ONCO |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 6 months | Every 9 days β better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.6 | 13.0 β better |
| Further details β not scored | ||
| Size | 59 MB | 24 MB |
| Age rating | 17+ | 4+ |
| Developer | Memorial Sloan Kettering Cancer Center | The University of Kansas |
In-app purchases
WE
No in-app purchases
ONCO
No in-app purchases





